These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37852646)

  • 21. [Proposal on new formulas for renal depth in the technetium-99m-mercaptoacetyltriglycine (MAG3) scintigraphy].
    Uchiyama K; Kuniyasu Y; Niio Y; Hasebe S; Yamada M; Shinohara H; Matsuoka S; Shima H; Obuchi M; Takizawa K; Honda M; Kawabe R; Kuwayama J; Iwasaki S; Ideura T
    Kaku Igaku; 1997 Mar; 34(3):159-66. PubMed ID: 9136524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
    Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
    Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can computed tomography volumetry of the renal cortex replace MAG3-scintigraphy in all patients for determining split renal function?
    Houbois C; Haneder S; Merkt M; Morelli JN; Schmidt M; Hellmich M; Mueller RU; Wahba R; Maintz D; Puesken M
    Eur J Radiol; 2018 Jun; 103():105-111. PubMed ID: 29803374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal artery stenosis secondary to Takayasu's arteritis demonstrated on Tc-99m MAG3 renal scan correlation with conventional angiography.
    Caldwell CM; Shanley DJ; Gayle EL
    Clin Nucl Med; 1996 Jan; 21(1):76-7. PubMed ID: 8741903
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Tc-99m MAG3 dynamic renal scintigraphy with an aneurysmal type renal arteriovenous fistula.
    Horita Y; Nakamura S; Hirashima S; Tadokoro M; Taura K; Suyama N; Sakamoto I; Nishikido M; Miyazaki M; Kohno S
    Clin Nucl Med; 2003 May; 28(5):429-31. PubMed ID: 12702950
    [No Abstract]   [Full Text] [Related]  

  • 27. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
    Afshan A; Sohaib M; Jehangir M
    Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
    Moran JK
    Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of warm and cold ischemia on renal function after partial nephrectomy.
    Funahashi Y; Yoshino Y; Sassa N; Matsukawa Y; Takai S; Gotoh M
    Urology; 2014 Dec; 84(6):1408-12. PubMed ID: 25432829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Individual Renal Function Using
    Lim HJ; Choi SH
    In Vivo; 2022; 36(1):206-211. PubMed ID: 34972716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine.
    Gates GF
    Clin Nucl Med; 2004 Apr; 29(4):231-7. PubMed ID: 15096969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy.
    Tantawy MN; Jiang R; Wang F; Takahashi K; Peterson TE; Zemel D; Hao CM; Fujita H; Harris RC; Quarles CC; Takahashi T
    BMC Nephrol; 2012 Dec; 13():168. PubMed ID: 23228112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
    Taylor A; Ziffer JA; Eshima D
    Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
    O'Malley JP; Ziessman HA; Chantarapitak N
    Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tc-99m MAG3 scintigraphy in a newborn with acute renal vein thrombosis.
    Izquierdo V; Gómez D; Macías E; Gellida J; Siurana R; Moralejo J; de Vírgala CM
    Clin Nucl Med; 1999 Apr; 24(4):287-8. PubMed ID: 10466536
    [No Abstract]   [Full Text] [Related]  

  • 38. Intestinal activity on Tc-99m MAG3 scintigraphy in a patient after renal transplant may interfere with interpretation.
    Barnes S; Shih WJ; Saylor M
    Clin Nucl Med; 2000 Aug; 25(8):643-4. PubMed ID: 10944031
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quantitative indicators of renal function in scintigraphy with mercaptoacetyl-triglycine in patients with transplanted kidneys (99m TC MAG3 in the quantitative evaluation of the transplanted kidney)].
    Beatović S; Krajnović-Jaksić E; Blagojević-Lazić R; Djukanović Lj; Han R
    Srp Arh Celok Lek; 1996; 124 Suppl 1():194-6. PubMed ID: 9102904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of differential renal function by means of 99mTc-MAG3: integral method or Rutland-Patlak plot?
    Piepsz A; Ham H
    Eur J Nucl Med; 1999 Dec; 26(12):1627-8. PubMed ID: 10638417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.